Depression and sarcopenia: a Mendelian randomization analysis

Psychiatr Genet. 2023 Aug 1;33(4):145-151. doi: 10.1097/YPG.0000000000000346. Epub 2023 Jun 12.

Abstract

Background: The association between depression and sarcopenia has been reported in observational studies but the causality of depression on sarcopenia remained unknown. We aimed to assess the causal effect between major depressive disorder (MDD) and sarcopenia using the two-sample Mendelian randomization (MR) method.

Methods: A set of genetics instruments were used for analysis, derived from publicly available genetic summary data. Clinically, appendicular lean mass (ALM) and low hand grip strength (LHGS) have been widely used for the diagnosis of sarcopenia. Inverse-variance weighted method, weighted median method, MR-Egger, MR Pleiotropy RESidual Sum and Outlier test were used for the bidirectional MR analyses.

Results: No evidence for an effect of MDD on sarcopenia risk was found. MDD was not associated with ALM [effect = -0.17 (-0.60 to 0.27), P = 0.449] and LHGS [effect = 0.24 (-0.46 to 0.93), P = 0.506]. Sarcopenia was not associated with MDD [ALM: odds ratio (OR) = 0.999 (0.996-1.001), P = 0.374; LHGS: OR = 0.999 (0.996-1.002), P = 0.556].

Conclusion: MDD and Sarcopenia might mutually have no causal effect on each other.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Depression / genetics
  • Depressive Disorder, Major* / genetics
  • Genome-Wide Association Study
  • Hand Strength
  • Humans
  • Mendelian Randomization Analysis
  • Odds Ratio